+ All Categories
Home > Documents > Document Date: SAP Version 2: 25-November-2019 · 2020. 8. 31. · Clinical benefit rate (CBR)...

Document Date: SAP Version 2: 25-November-2019 · 2020. 8. 31. · Clinical benefit rate (CBR)...

Date post: 31-Jan-2021
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
60
Official Title: A Multicenter, Open-Label, Single-Arm Study of Pertuzumab in Combination With Trastuzumab and a Taxane in First Line Treatment of Patients With HER2- Positive Advanced (Metastatic or Locally Recurrent) Breast Cancer NCT Number: NCT01572038 Document Date: SAP Version 2: 25-November-2019
Transcript
  • Official Title: A Multicenter, Open-Label, Single-Arm Study of Pertuzumab in Combination With Trastuzumab and a Taxane in First Line Treatment of Patients With HER2- Positive Advanced (Metastatic or Locally Recurrent) Breast Cancer

    NCT Number: NCT01572038

    Document Date: SAP Version 2: 25-November-2019

    https://clinicaltrials.gov/show/NCT01572038


Recommended